You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: a multicenter clinical study
|
|---|---|
| Published in |
Arthritis Research & Therapy, March 2014
|
| DOI | 10.1186/ar4520 |
| Pubmed ID | |
| Authors |
Dandan Wang, Jing Li, Yu Zhang, Miaojia Zhang, Jinyun Chen, Xia Li, Xiang Hu, Shu Jiang, Songtao Shi, Lingyun Sun |
| Abstract |
Umbilical cord (UC)-derived mesenchymal stem cells (MSCs) have shown a good safety profile and therapeutic effect in severe and refractory systemic lupus erythematosus (SLE) in our single-center pilot study. The present multicenter clinical trial was undertaken to assess the safety and efficacy of allogenic UC MSC transplantation (MSCT) in active and refractory SLE patients. |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | 75% |
| Iraq | 1 | 25% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 75% |
| Practitioners (doctors, other healthcare professionals) | 1 | 25% |
Mendeley readers
The data shown below were compiled from readership statistics for 197 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Iran, Islamic Republic of | 1 | <1% |
| Japan | 1 | <1% |
| United Kingdom | 1 | <1% |
| Ireland | 1 | <1% |
| Unknown | 193 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 31 | 16% |
| Student > Master | 23 | 12% |
| Student > Bachelor | 21 | 11% |
| Researcher | 20 | 10% |
| Other | 16 | 8% |
| Other | 35 | 18% |
| Unknown | 51 | 26% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 64 | 32% |
| Agricultural and Biological Sciences | 24 | 12% |
| Biochemistry, Genetics and Molecular Biology | 22 | 11% |
| Immunology and Microbiology | 12 | 6% |
| Nursing and Health Professions | 4 | 2% |
| Other | 13 | 7% |
| Unknown | 58 | 29% |
Attention Score in Context
This research output has an Altmetric Attention Score of 20. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 July 2023.
All research outputs
#1,835,584
of 25,371,288 outputs
Outputs from Arthritis Research & Therapy
#283
of 3,381 outputs
Outputs of similar age
#18,056
of 237,675 outputs
Outputs of similar age from Arthritis Research & Therapy
#3
of 46 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,381 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.2. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 237,675 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 46 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.